NCT05752526View on ClinicalTrials.gov

A Study of Diclofenac Gel in Women With Primary Dysmenorrhea

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

May 19, 2023

Primary Completion Date

October 10, 2023

Study Completion Date

April 26, 2024

Conditions
Dysmenorrhea Primary
Interventions
DRUG

Diclofenac 1%

vaginal hydrogel containing 1% Diclofenac

DRUG

Diclofenac 3%

vaginal hydrogel containing 3% Diclofenac

DRUG

Placebo

vaginal hydrogel, no active ingredient

Trial Locations (1)

Unknown

PARC Clinical Research, Adelaide

Sponsors
All Listed Sponsors
lead

Daré Bioscience, Inc.

INDUSTRY